Advanced and Metastatic NSCLC
1 clinical trials · Condition
◉ Watch Advanced and Metastatic NSCLC
| Record | Firm | Date |
|---|---|---|
| Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer (NCT06704620) | Tianjin Medical University Cancer Institute and Hospital | 2024-12-01 |
Track Advanced and Metastatic NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.